Spruce Biosciences Announces Results of 2026 Annual Meeting and Election of Directors

Spruce Biosciences, Inc. filed an 8-K report detailing the results of its 2026 Annual Meeting of Stockholders held on May 21, 2026. Stockholders voted on several key proposals, including the election of Class III directors. Michael Grey, Camilla V. Simpson, M.Sc., and Javier Szwarcberg, M.D., MPH were elected to serve until the 2029 Annual Meeting. Additionally, stockholders ratified the selection of BDO USA, P.C. as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. An advisory vote on the compensation of named executive officers was approved, and stockholders expressed a preference for future advisory votes on executive compensation to be held every year. In response to the voting results, the Board of Directors determined that the company will hold such advisory votes annually until the next required frequency vote, which must occur by the 2032 Annual Meeting. The meeting achieved a quorum with approximately 65.86% of outstanding shares represented.